US Patent 7527800 Influenza hemagglutinin and neuraminidase variants

Patent 7527800 was granted and assigned to MedImmune on May, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

MedImmune

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7527800

Date of Patent

May 5, 2009

Patent Application Number

11133360

Date Filed

May 20, 2005

Patent Citations Received

‌

US Patent 12024552 Ha binding agents

Patent Primary Examiner

‌

Bruce Campell

Patent abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7527800 Influenza hemagglutinin and neuraminidase variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API